{"nct_id":"NCT02631538","title":"Safety and Efficacy Study of Subcutaneous Belimumab and Intravenous Rituximab Co-administration in Subjects With Primary Sjogren's Syndrome","status":"COMPLETED","status_verified_date":"2021-05","start_date":"2016-02-17","start_date_type":"ACTUAL","primary_completion_date":"2020-06-23","primary_completion_date_type":"ACTUAL","completion_date":"2020-06-23","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}